Halozyme wins court order to block Merck's injected Keytruda in select European markets - Reuters
Halozyme wins court order to block Merck's injected Keytruda in select European markets Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQOENfMU9mT1RqQTl2QlZBUjgzTi1ZTFZWZThEMXk5YTJRMC1jSlA4VGRQX1p0a2tmQ2ppc0M4bURDLUdJTDBkQVNOcGFrYi1rWTU3Wjk1Uk44Y2QyMEx2MmlyS2drLWRQUFRUTW1VNEZteW56VEVWQjBQTFBNQmxWMGk3ZGpGRXlFX3liNjJxd3l1ZUI0OFlFczRpRjRlekU1UUhNSnZhNks0TndBV2lCMnJnd0EyNXRaR2pRWE1lTGhxVjBUMVVMRFB0RFpKUQ?oc=5" target="_blank">Halozyme wins court order to block Merck's injected Keytruda in select European markets</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Teva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PMUS appeals court weighs block on Kennedy's vaccine panel appointments - Reuters
US appeals court weighs block on Kennedy's vaccine panel appointments Reuters
October 6, 2026 at 06:41 PMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMPharma lobby sues Trump administration over Medicare drug price cuts - Reuters
Pharma lobby sues Trump administration over Medicare drug price cuts Reuters
October 7, 2026 at 05:08 PMRosatom says it wins tribunal ruling in Finnish nuclear plant dispute - Reuters
Rosatom says it wins tribunal ruling in Finnish nuclear plant dispute Reuters
October 10, 2026 at 09:05 AM